|
RALB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07369999949414E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26729999827546E-08 |
| Normal-vs-Stage2 |
3.457500E-02 |
| Normal-vs-Stage3 |
8.098700E-03 |
| Normal-vs-Stage4 |
1.106840E-01 |
| Stage1-vs-Stage2 |
3.575200E-01 |
| Stage1-vs-Stage3 |
4.490300E-02 |
| Stage1-vs-Stage4 |
4.994400E-02 |
| Stage2-vs-Stage3 |
6.465400E-01 |
| Stage2-vs-Stage4 |
4.793800E-01 |
| Stage3-vs-Stage4 |
6.700200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50111999999147E-05 |
| Normal-vs-AfricanAmerican |
4.660400E-03 |
| Normal-vs-Asian |
2.391200E-04 |
| Caucasian-vs-AfricanAmerican |
5.696600E-01 |
| Caucasian-vs-Asian |
7.163700E-02 |
| AfricanAmerican-vs-Asian |
3.331800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.238120E-03 |
| Normal-vs-Female |
1.32880000003333E-07 |
| Male-vs-Female |
2.522600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.16179999643774E-08 |
| Normal-vs-Age(41-60Yrs) |
1.90641999999741E-05 |
| Normal-vs-Age(61-80Yrs) |
1.544180E-01 |
| Normal-vs-Age(81-100Yrs) |
5.122000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.375800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.896230E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.809400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.789800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.699400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.258200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.811800E-01 |
| Classical-VS-Follicular |
1.017150E-01 |
| Classical-VS-Other |
3.008000E-01 |
| Classical-VS-Normal |
7.76830000326356E-09 |
| Tall-VS-Follicular |
8.244000E-01 |
| Tall-VS-Other |
5.976800E-01 |
| Tall-VS-Normal |
2.162100E-02 |
| Follicular-VS-Other |
7.755000E-01 |
| Follicular-VS-Normal |
3.627900E-02 |
| Other-VS-Normal |
6.360200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.627630E-04 |
| Normal-vs-N1 |
1.111830E-01 |
| N0-vs-N1 |
3.884400E-01 |
|
|
